Erin McCreary
Quick facts
Marketed products
- Lilly Bamlanivimab
- Lilly Bamlanivimab + Etesevimab · Infectious Disease / Virology
Bamlanivimab and etesevimab are monoclonal antibodies that bind to the SARS-CoV-2 spike protein to neutralize the virus and prevent infection. - Regeneron Casirivimab + Imdevimab · Infectious Disease / Virology
This combination of two monoclonal antibodies binds to the SARS-CoV-2 spike protein to neutralize the virus and prevent infection of human cells.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: